Pharmacists play a critical role in preventing opioid deaths by increasing statewide access to naloxone.
As of October 1, 2020, South Dakota pharmacists with an active license can dispense naloxone under the statewide standing order to any eligible person who is at risk of an opioid-related overdose or able to assist an at-risk person (a family member or friend).
South Dakota pharmacists must complete the following requirements to participate.
7 Steps to Dispense Naloxone under the Statewide Standing Order
Click and jump to each step for further details.
Step 1: Print the Statewide Standing Order
Treat the standing order as you would any other prescription. Pharmacists should follow all usual steps as they would any other prescription, such as record keeping, documentation, billing, and labeling requirements.
The differences are:
- Dr. Carpenter (including NPI#) is listed as the prescriber for the medication
- The Eligibility Assessment Form must be completed with the eligible individual before dispensing naloxone
- You must provide printed educational material when counseling the patient (learn more in Step 5)
Participating pharmacies must keep a printed copy of the statewide standing order on premises.
Step 2: Become a Participating Pharmacy
If your facility plans to dispense naloxone under the standing order, join the statewide participating pharmacy list by providing your pharmacy information to the SD Department of Social Services. This information will be used to generate a public list of pharmacies, making it easier for those seeking naloxone to obtain it. It will also allow us to contact your pharmacy should there be changes to the standing order.
Step 3: Complete 1 Hour of Training
Pharmacies choosing to dispense naloxone under the statewide standing order must complete at least one hour of training related to naloxone dispensing and administration. Suitable trainings include, but are not limited to:
- Naloxone: Important Considerations and Appropriate Use in Opioid Toxicity
Home study CPE program, provided by the South Dakota State University College of Pharmacy & Allied Health Professionals
- Overdose Prevention and Naloxone Rescue Kits for Prescribers and Pharmacists
Online educational program that models how to provide a patient with overdose education and a naloxone rescue kit, provided by the Boston University School of Medicine
- Module 22: Preventing Opioid Overdose with Education and Naloxone Rescue Kits
Free online course that educates on opioid overdose and prescribing naloxone, provided by the Providers Clinical Support System
Any program that provides the pharmacist with at least one hour of naloxone education is sufficient.
Step 4: Print Eligibility Assessment Forms
Pharmacies must complete an Eligibility Assessment Form for every individual receiving naloxone.
Assessment forms must be:
- Filled out with the eligible individual, before dispensing naloxone
- Maintained with pharmacy records for at least two years
- Be available for inspection and copying by the South Dakota Board of Pharmacy
Step 5: Provide Patient Education
Patients who receive naloxone under the standing order must receive verbal and written education about:
- Signs of an overdose
- Overdose response steps
- How to use naloxone
The SD Department of Social Services has developed Naloxone Brochures for pharmacy use. These brochures can be requested and shipped to your facility at no cost.
Step 6: Submit Quarterly Reports
In order to save lives, a top priority for the SD Departments of Health and Social Services is to expand access to naloxone. Pharmacies play a huge role in helping us distribute and monitor the number of naloxone kits dispensed. The quarterly report form is quick and easy to fill out.
- January 1 – March 31
Due April 30
- April 1 – June 30
Due July 31
- July 1 – September 30
Due October 31
- October 1 – December 31
Due January 31
Step 7: Submit Naloxone Reimbursement
Naloxone reimbursement is available for individuals without:
- Insurance (including Medicaid) or a 3rd party payor source; or
- The ability to pay due to financial circumstances
Pharmacies seeking direct deposit of reimbursement must submit a substitute W-9.